Industry stakeholder meeting on Brexit and operation of the centralised procedure for human medicinal productsEventCorporateBrexit
Date Friday, 23 March 2018 Location European Medicines Agency, Amsterdam, the Netherlands The purpose of this meeting is to update European Union trade associations on the Agency's Brexit preparedness activities. Documents Agenda – Industry stakeholder meeting on Brexit and operation of the centralised procedure for human medicinal productsDraftReference Number: EMA/132201/2018 English (EN) (62.17 KB - PDF)First published: 02/03/2018Last updated: 02/03/2018ViewMinutes - Industry stakeholder meeting on Brexit and operation of the centralised procedure for human medicinal products English (EN) (260.25 KB - PDF)First published: 02/05/2018Last updated: 02/05/2018ViewPresentation - United Kingdom's withdrawal from the European Union (Olga Solomon) English (EN) (213.16 KB - PDF)First published: 02/05/2018Last updated: 02/05/2018ViewPresentation - Operational preparedness for Brexit and re-allocation of United Kingdom product portfolio in the centralised procedure English (EN) (711.89 KB - PDF)First published: 02/05/2018Last updated: 02/05/2018ViewPresentation - Joint industry presentation - Industry stakeholder meeting on Brexit and operation of the centralised procedure for human medicinal products English (EN) (412.64 KB - PDF)First published: 02/05/2018Last updated: 02/05/2018ViewPresentation - 2018 European Medicines Agency (EMA) and industry stakeholder interactions on Brexit related topics (Marie-Helene Pinheiro) English (EN) (115.81 KB - PDF)First published: 02/05/2018Last updated: 02/05/2018View Registration Registration by invitation only Related content Brexit-related guidance for companiesShare this pageHow useful do you find this page?12345